NASDAQ:ALXN - Nasdaq -
A former Alexion Pharmaceuticals Inc. executive avoided jail after pleading guilty to sharing information about the company’s planned purchase of another company in 2020 with a boyhood friend.
Mentions: PTLA
It's not likely.
Alexion (ALXN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With shares at record-high prices now, very few on Wall Street still see upside in the stock.
ALXN vs. TECH: Which Stock Is the Better Value Option?
Mentions: TECH
The FDA grants a Breakthrough Therapy designation to AbbVie's (ABBV) Venclexta in combination with azacitidine for treating adult patients with higher risk myelodysplastic syndrome.
Ultomiris, the successor to Alexion Pharmaceuticals Inc's (NASDAQ: ALXN) paroxysmal nocturnal hemoglobinuria (PNH) drug Soliris, is on track for another blockbuster...
Mentions: AZN
The FDA grants a Fast Track status to Bayer's (BAYRY) DA01 cell therapy which is being developed for the treatment of Parkinson's disease.
Mentions: RGEN
Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc. (ALXN). The stock has soared amid the pandemic after its vaccine became instrumental in the fight against coronavirus.
Moderna, known for its success in the COVID-19 vaccine, has entered the big league with its addition to the S&P 500 Index.
Probably so.
Mentions: AZN
Moderna, Inc (NASDAQ: MRNA) gapped up 6.64% Friday morning after it was announced the company will join the S&P 500 beginning July 21. The pharmaceutical company,...
Moderna stock rocketed to another record high Friday on news it would join the S&P 500 on Wednesday, replacing soon-to-be-acquired Alexion.
Moderna (MRNA) stock is on the rise Friday as the company prepares to join the S&P 500 next week replacing Alexion Pharmaceuticals (ALXN).
Stock futures were moving higher, while Asian and European equities were mixed as Covid-19 concerns remained in focus.
Stock futures were moving higher, while Asian and European equities were mixed as Covid-19 concerns remained in focus.
Galapagos (GLPG) announces data from multiple studies evaluating its two inflammatory candidates - GLPG3970 and GLPG3667. Stock down.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Alexion (ALXN) could produce exceptional returns because of its solid growth attributes.
AstraZeneca has a Covid vaccine, but the company is also a specialist in cancer treatments, and it supplies medicine for a host of other diseases.
AstraZeneca (AZN) obtains European Commission's permission for the acquisition of Alexion. The deal is expected to close in the third quarter of 2021.
ALXN vs. GMAB: Which Stock Is the Better Value Option?
Mentions: GMAB
A Relative Strength Rating upgrade for Translate Bio shows improving technical performance.
GlaxoSmithKline Plc has hired two banks to help advise on plans to list its consumer unit next year and defend against a potential activist campaign from Elliott Investment Management, according to people familiar with the matter.